Pilot Study of Cognitively-Enhanced Interpersonal and Social Rhythms Therapy for Depression

Status: Complete
Funded: $2,016

Major depressive disorder (MDD) involves significant morbidity, suicide risk, and recurrent hospitalisations.

After recovery from a depressive episode, individuals often continue to experience problems with cognitive (i.e., thinking,  organisation, memory) and general functioning, and report these problems to be distressing and disabling. Treatment of severe depression in New Zealand involves short-term treatment by Specialist Mental Health Services (SMHS) then discharge back to primary care. Following discharge, readmission to inpatient and outpatient services is very common. 

We are therefore interested in developing a treatment for people with severe depression that could be used to aid in cognitive and functional recovery following discharge from SMHS.

Researcher // Dr Katie Douglas – University of Otago

Katie is a Senior Research Fellow and a Registered Clinical Psychologist. In the past five years, Katie has been awarded six research grants as Principal Investigator. Over the same time period, she has been a named co-investigator on six funded research projects. Katie has extensive experience in clinical trial methodology and is currently involved in several clinical trials.

More About Dr Katie Douglas
Light Therapy

What is Depression?

Depression (major depressive disorder) is a common and serious medical illness that negatively affects how you feel, the way you think and how you act. Fortunately, it is also treatable. Depression causes feelings of sadness and/or a loss of interest in activities once enjoyed. It can lead to a variety of emotional and physical problems and can decrease a person’s ability to function at work and at home.

0 %
Of New Zealand adults have been diagnosed with depression at some time in their lives.
0 %
Depression rates are significantly higher amongst women than men.
0 %
Of women aged between 35-44 years have suffered depression.
0 %
Anxiety and depressive disorders are the second leading cause of health loss for New Zealanders.

Stay in touch with CMRF

// Get all the latest news and insights to your inbox